Safety of recombinant human deoxyribonuclease as a rescue treatment for persistent atelectasis in newborns

Abstract

rhDNase treatment is a safe option and may be used as an effective method for the management of persistent atelectasis in newborns, which is resistant to other conventional treatment methods.